Evidence map›Paper›PMID 30159586›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation.

Otakar Belohlavek, Monika Jaruskova, Magdalena Skopalova, Gabriela Szarazova, Katerina Simonova

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evaluation of a visual interpretation method for tau-PET withAlzheimer's & dementia (Amsterdam, Netherlands) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Otakar BelohlavekDepartment of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic. otakar.belohlavek@homolka.cz.ORCID 0000-0002-2430-2527
Monika JaruskovaDepartment of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
Magdalena SkopalovaDepartment of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
Gabriela SzarazovaDepartment of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
Katerina SimonovaDepartment of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe investigated whether the reproducibility of standard visual reporting (STD method) in flutemetamol (FMM) PET can be improved using a newly introduced method that uses grey matter edges derived from the perfusion phase (GM-EDGE method).

methodsTwo-phase FMM PET was performed in 121 patients with mild cognitive impairment. Five nuclear medicine physicians blindly and independently evaluated all late-phase scans, initially employing the STD method and later the GM-EDGE method. A five-point scale was used to express the degree of amyloid positivity, and a binary classification (positive/negative) was used in combination with subjective confidence (five-point scale). Multirater Fleiss' kappa, intraclass correlation coefficient (ICC) and inter-rater reliability (Cohen's kappa) were determined for the STD and GM-EDGE methods.

resultsThe weighted Cohen's kappa values for the five-point measure of amyloid positivity ranged from 0.63 to 0.73 (median 0.70) for the STD method and from 0.76 to 0.89 (median 0.80) for the GM-EDGE method (ICC 0.84, 95% CI 0.79-0.88, for the STD method; 0.91, 95% CI 0.89-0.94, for the GM-EDGE method). The nonweighted Cohen's kappa value for the binary classification ranged from 0.73 to 0.93 (median 0.82) for the STD method and 0.90 to 0.97 (median 0.93) for the GM-EDGE method (Fleiss' kappa 0.82, 95% CI 0.77-0.88, for the STD method; 0.93, 95% CI 0.87-0.99, for the GM-EDGE method). The GM-EDGE method resulted in significantly greater subjective confidence in the readings of four physicians (p < 0.010). The binary classification was concordant among all five physicians in 80.8% of the scans using the STD method and in 91.6% of the scans using the GM-EDGE method (p = 0.016).

conclusionThe newly introduced GM-EDGE method was associated with significantly higher inter-rater agreement among physicians and higher subjective confidence in the reading. The method is easy to implement in clinical practice, especially when the perfusion phase is utilized clinically.

Indexed as

Image Processing, Computer-AssistedPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overAmyloid beta-PeptidesCognitive DysfunctionGray MatterHumansMaleMiddle AgedAmyloid beta-PeptidesAmyloidBrainDementiaFlutemetamolPositron emission tomographyReproducibility

Identifiers

PMID30159586
PMCPMC6333723

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.